PuSH - Publikationsserver des Helmholtz Zentrums München

Cecil, A. ; Gentschev, I.* ; Prehn, C. ; Hauck, S.M. ; Witting, M. ; Petrov, I.* ; Ye, M.* ; Othman, E.M.* ; Szalay, A.A.*

Endogenous gut microbiome and implanted intranasal E. coli-Nissle modulate cancer tissues metabolism in 4T1 syngeneic tumor bearing mice.

BIOMED. PHARMACOTHER. 193:118750 (2025)
Verlagsversion Forschungsdaten DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Despite recent progress in the diagnosis and treatment of advanced cancers, the overall patient treatment outcome did not substantially improve over the last years. Therefore, developing novel therapies, which may also work synergistically in combination with the conventional therapies is crucial. One promising new therapeutic approach is bacterium-mediated cancer therapy. In the current work, we describe the influence of the gut microbiome and intranasal E. coli Nissle applications on the metabolism in cancer tissues of 4T1 syngeneic tumor bearing mice. Here we found that after gut microbiome depletion and/or E. coli Nissle treatment the ratios of ADMA/Arginine, Putrescine/Ornithine and Kynurenine/Tryptophan as well as the total concentration of Carnosine, Kynurenine and H1 (synonymus for all sugars detectable) are significantly altered in tumor tissues of as the result of treatment. In conclusion, our current data show that E. coli Nissle bacteria facilitating metabolic modulation of tumors, a finding could be important for improved cancer therapy in patients.
Impact Factor
Scopus SNIP
Altmetric
0.000
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter 4t1 Syngeneic Tumor ; Anticancer ; E. Coli Nissle ; Gut Microbiome
Sprache englisch
Veröffentlichungsjahr 2025
HGF-Berichtsjahr 2025
ISSN (print) / ISBN 1950-6007
e-ISSN 0753-3322
Quellenangaben Band: 193, Heft: , Seiten: , Artikelnummer: 118750 Supplement: ,
Verlag Elsevier
Verlagsort Paris
Begutachtungsstatus Peer reviewed
POF Topic(s) 30505 - New Technologies for Biomedical Discoveries
30203 - Molecular Targets and Therapies
Forschungsfeld(er) Enabling and Novel Technologies
PSP-Element(e) A-630710-001
G-505700-001
Scopus ID 105021836009
PubMed ID 41240551
Erfassungsdatum 2025-11-19